Sensitivity and Specificity of Cetuximab-IRDye800CW to Identify Regional Metastatic Disease in Head and Neck Cancer

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-16-2968
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Sensitivity and Specificity of Fluorescent Immunoguided Neoplasm Detection in Head and Neck Cancer Xenografts

Archives of Otolaryngology–Head & Neck Surgery
2007English

Platinum-Based Chemotherapy Plus Cetuximab in Head and Neck Cancer

New England Journal of Medicine
Medicine
2008English

Evaluation of Weekly Paclitaxel, Carboplatin, and Cetuximab in Head and Neck Cancer Patients With Incurable Disease

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2016English

Rationale and Budget Impact of Bimonthly Use of Cetuximab in Patients With Recurrent and/or Metastatic Head and Neck Cancer

Head and Neck
Otorhinolaryngology
2019English

Cetuximab in Locally Advanced Head-And-Neck Cancer: Defining the Population

Current Oncology
Oncology
2010English

Cetuximab Promotes Epithelial to Mesenchymal Transition and Cancer Associated Fibroblasts in Patients With Head and Neck Cancer

Oncotarget
Oncology
2015English

Lymphotoxin-Β Interacts With Methylated EGFR to Mediate Acquired Resistance to Cetuximab in Head and Neck Cancer

Clinical Cancer Research
Cancer ResearchOncology
2017English

A Patient-Derived Somatic Mutation in the Epidermal Growth Factor Receptor Ligand-Binding Domain Confers Increased Sensitivity to Cetuximab in Head and Neck Cancer

European Journal of Cancer
Cancer ResearchOncology
2013English

Decrease in Sensitivity to Plutinum Analogue in Head and Neck Cancer Following Multiple Applications.

Japanese jornal of Head and Neck Cancer
1996English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy